Company Filing History:
Years Active: 2012
Title: Innovations in Cancer Treatment by Dave Gingrich
Introduction
Dave Gingrich is an accomplished inventor based in Pittsburgh, PA, known for his significant contributions to cancer treatment methodologies. With a focus on individualizing chemotherapy, his work aims to enhance patient outcomes through innovative approaches.
Latest Patents
Dave Gingrich holds a patent for "Methods for selecting active agents for cancer treatment." This invention provides methods for individualizing chemotherapy, particularly neoadjuvant chemotherapy. It includes techniques for predicting a cancer patient's response to treatment by assessing the probability of a positive response to candidate agents prior to surgery. The invention involves culturing malignant cells from a patient's biopsy specimen and testing these cells for resistance or sensitivity to various candidate agents. Additionally, it offers methods for accurately scoring and interpreting assay results, which can predict a patient's pathological complete response upon receiving the corresponding treatment regimen.
Career Highlights
Gingrich is currently associated with Precision Therapeutics, Inc., where he continues to develop innovative solutions in cancer treatment. His work is pivotal in advancing personalized medicine, particularly in the field of oncology.
Collaborations
Dave collaborates with notable colleagues, including Zhibao Mi and Mike Gabrin, who contribute to the research and development efforts at Precision Therapeutics, Inc.
Conclusion
Dave Gingrich's innovative work in cancer treatment exemplifies the potential of personalized medicine to improve patient care. His contributions through patented methodologies are paving the way for more effective chemotherapy options.